AI is being used across industries, and its role in drug discovery is pivotal as pharmaceutical companies seek to accelerate the development of new treatments for diseases like malaria and HIV.
A recent newspaper report highlighting that Nigeria loses approximately $1.1 billion yearly to malaria underscores a critical public health and economic challenge that demands urgent attention.
Dr Daniel Madandi, Director of WHO’s Global Malaria Programme, encouraged the submission of additional products to expand the range of diagnostic tools available to countries.